Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
hpp404 (1 trial)
hpp593 (1 trial)
hpp854 (1 trial)
Alzheimer Disease (Phase 1)
Atrophy (Phase 1)
Cognitive Dysfunction (Phase 1)
Hypokinesia (Phase 1)
Muscular Atrophy (Phase 1)
Overweight (Phase 2)
Weight Loss (Phase 2)
Trials (3 total)
Trial APIs (3 total)